Current State of Integrated "Hybrid" Coronary Revascularization

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalSeminars in Thoracic and Cardiovascular Surgery
Volume21
Issue number3
DOIs
StatePublished - Sep 2009

Fingerprint

Percutaneous Coronary Intervention
Coronary Artery Bypass
Mammary Arteries
Arteries
Drug-Eluting Stents
Comorbidity
Coronary Artery Disease
Randomized Controlled Trials
Morbidity
Transplants
Population

Keywords

  • coronary surgery
  • hybrid revascularization
  • minimally invasive
  • percutaneous coronary intervention
  • robotics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Current State of Integrated "Hybrid" Coronary Revascularization. / DeRose, Joseph.

In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 21, No. 3, 09.2009, p. 229-236.

Research output: Contribution to journalArticle

@article{4bfa546d658640208b172f3da604b167,
title = "Current State of Integrated {"}Hybrid{"} Coronary Revascularization",
abstract = "The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.",
keywords = "coronary surgery, hybrid revascularization, minimally invasive, percutaneous coronary intervention, robotics",
author = "Joseph DeRose",
year = "2009",
month = "9",
doi = "10.1053/j.semtcvs.2009.08.004",
language = "English (US)",
volume = "21",
pages = "229--236",
journal = "Seminars in Thoracic and Cardiovascular Surgery",
issn = "1043-0679",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Current State of Integrated "Hybrid" Coronary Revascularization

AU - DeRose, Joseph

PY - 2009/9

Y1 - 2009/9

N2 - The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.

AB - The long-term benefits of a left internal mammary artery bypass graft to the left anterior descending artery (LAD) have been well described. As the patient population with multivessel coronary artery disease has grown older with greater comorbidities, less invasive approaches to revascularization have been explored. The use of drug-eluting stents has minimized the morbidity of revascularization but has failed to match the durability of coronary artery bypass grafting (CABG). Hybrid coronary revascularization (HCR) is the planned use of minimally invasive surgical techniques for left internal mammary artery-LAD grafting and the use of percutaneous coronary interventions (PCI) for non-LAD target revascularization. The optimal timing and order of revascularization in HCR remains unclear. Novel operating suites with surgical and fluoroscopic capabilities have begun to support the performance of simultaneous minimally invasive CABG and PCI. The role of HCR compared to both PCI and conventional CABG awaits the results of ongoing randomized clinical trials.

KW - coronary surgery

KW - hybrid revascularization

KW - minimally invasive

KW - percutaneous coronary intervention

KW - robotics

UR - http://www.scopus.com/inward/record.url?scp=70449707640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449707640&partnerID=8YFLogxK

U2 - 10.1053/j.semtcvs.2009.08.004

DO - 10.1053/j.semtcvs.2009.08.004

M3 - Article

VL - 21

SP - 229

EP - 236

JO - Seminars in Thoracic and Cardiovascular Surgery

JF - Seminars in Thoracic and Cardiovascular Surgery

SN - 1043-0679

IS - 3

ER -